Detalhe da pesquisa
1.
HIV Diagnostics and Vaccines: It Takes Two to Tango.
J Infect Dis
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38451247
2.
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).
Lancet
; 392(10143): 232-243, 2018 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30047376
3.
Immunogenicity of 2 therapeutic mosaic HIV-1 vaccine strategies in individuals with HIV-1 on antiretroviral therapy.
NPJ Vaccines
; 9(1): 89, 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782902
4.
Towards Novel HIV-1 Serodiagnostic Tests without Vaccine-Induced Seroreactivity.
Microbiol Spectr
; 11(3): e0071523, 2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37222611
5.
Effect of baseline characteristics on the efficacy and safety of once-daily darunavir/ ritonavir in HIV-1-infected, treatment-naïve ARTEMIS patients at week 96.
HIV Clin Trials
; 12(6): 313-22, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22189150
6.
Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees.
Open Forum Infect Dis
; 8(1): ofaa606, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33511233
7.
Pharmacokinetics of darunavir/ritonavir and rifabutin coadministered in HIV-negative healthy volunteers.
Antimicrob Agents Chemother
; 54(10): 4440-5, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20660678
8.
Suboptimal adherence to darunavir/ritonavir has minimal effect on efficacy compared with lopinavir/ritonavir in treatment-naive, HIV-infected patients: 96 week ARTEMIS data.
J Antimicrob Chemother
; 65(7): 1505-9, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20498120
9.
Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17-22).
Lancet HIV
; 7(6): e410-e421, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32078815
10.
Does bacterial vaginosis modify the effect of hormonal contraception on HIV seroconversion.
AIDS
; 33(7): 1225-1230, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31048629
11.
Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women.
AIDS
; 21(13): 1771-7, 2007 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-17690576
12.
The influence of hormonal contraceptive use on HIV-1 transmission and disease progression.
Clin Infect Dis
; 45(3): 360-9, 2007 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17599316
13.
A decrease in albumin in early HIV type 1 infection predicts subsequent disease progression.
AIDS Res Hum Retroviruses
; 23(10): 1197-200, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17961104
14.
Higher pre-infection vitamin E levels are associated with higher mortality in HIV-1-infected Kenyan women: a prospective study.
BMC Infect Dis
; 7: 63, 2007 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-17594484
15.
Relationship between markers of HIV-1 disease progression and serum beta-carotene concentrations in Kenyan women.
Int J STD AIDS
; 18(3): 202-6, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17362556
16.
Etravirine combined with antiretrovirals other than darunavir/ritonavir for HIV-1-infected, treatment-experienced adults: Week 48 results of a phase IV trial.
SAGE Open Med
; 5: 2050312116686482, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28382208
17.
Vaginal washing and increased risk of HIV-1 acquisition among African women: a 10-year prospective study.
AIDS
; 20(2): 269-73, 2006 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-16511421
18.
HIV-1 acquisition and disease progression are associated with decreased high-risk sexual behaviour among Kenyan female sex workers.
AIDS
; 20(15): 1969-73, 2006 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-16988519
19.
High levels of cervical HIV-1 RNA during early HIV-1 infection.
AIDS
; 20(18): 2389-90, 2006 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-17117027
20.
Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women.
Clin Infect Dis
; 42(9): 1333-9, 2006 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16586394